Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;92(5):1112-1114.
doi: 10.1016/j.jaad.2025.01.013. Epub 2025 Jan 17.

Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision

Jaclyn N Roland-McGowan  1 , Steven Caleb Freeman  2 , Wenelia Baghoomian  3 , Bryan T Carroll  4 , Caroline Choi Kim  5 , Clara Curiel-Lewandrowski  6 , Emily Y Chu  7 , Erin L Foster  2 , Kelly Carter Nelson  8 , Kevin P White  2 , Michael E Ming  7 , Rebecca I Hartman  9 , Sancy A Leachman  10 , Stephanie Mengden-Koon  2 , Suephy C Chen  11 , Susan M Swetter  12 , Victor G Prieto  8 , Elizabeth Berry  10 , Wesley Y Yu  13
Affiliations

Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision

Jaclyn N Roland-McGowan et al. J Am Acad Dermatol. 2025 May.
No abstract available

Keywords: atypical nevi; dysplastic nevi; general dermatology; melanoma; patient decision aid; shared decision-making.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest Dr Yu has received research support from SkylineDx and has served as a scientific advisor to Castle Biosciences. Drs Roland-McGowan, Freeman, Baghoomian, Carroll, Kim, Curiel-Lewandrowski, Chu, Foster, Nelson, White, Ming, Hartman, Leachman, Mengden-Koon, Chen, Swetter, Prieto, and Berry have no conflicts of interest to declare.

Figures

Fig 1.
Fig 1.
Front and back of final DN PDA. DN, Dysplastic nevi; PDA, patient decision aid.
See this image and copyright information in PMC

References

    1. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012;67(1):1.e1–16; quiz 17-8. 10.1016/j.jaad.2012.02.047. - DOI - PMC - PubMed
    1. Elwyn G, Burstin H, Barry MJ, et al. A proposal for the development of national certification standards for patient decision aids in the US. Health Policy Amst Neth. 2018;122(7):703–706. 10.1016/j.healthpol.2018.04.010 - DOI - PubMed
    1. Kim CC, Swetter SM, Curiel-Lewandrowski C, et al. Addressing the knowledge gap in clinical recommendations for management and complete excision of clinically atypical nevi/dysplastic nevi pigmented lesion subcommittee consensus statement. JAMA Dermatol. 2015;151(2):212–218. 10.1001/jamadermatol.2014.2694 - DOI - PubMed
    1. Kim CC, Berry EG, Marchetti MA, et al. Risk of subsequent cutaneous melanoma in moderately dysplastic nevi excisionally biopsied but with positive histologic margins. JAMA Dermatol. 2018;154(12):1401–1408. 10.1001/jamadermatol.2018.3359 - DOI - PMC - PubMed
    1. Coulter A, Stilwell D, Kryworuchko J, Mullen PD, Ng CJ, van der Weijden T. A systematic development process for patient decision aids. BMC Med Inform Decis Mak. 2013;13(Suppl 2):S2. 10.1186/1472-6947-13-S2-S2 - DOI - PMC - PubMed